Manufacturers Life Insurance Company, The Citius Pharmaceuticals, Inc. Transaction History

Manufacturers Life Insurance Company, The

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.87 $43,610 - $92,671	-49,557 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$1.38 - $1.89 $68,388 - $93,662	49,557 New	49,557 $88,000
Q1 2022 May 20, 2022	SELL	$1.38 - $1.89 $7,714 - $10,565	-5,590 Reduced 10.14%	49,557 $89,000
Q4 2021 Feb 16, 2022	BUY	$1.51 - $2.2 $66,378 - $96,709	43,959 Added 392.91%	55,147 $85,000
Q3 2021 Nov 12, 2021	SELL	$1.74 - $2.6 $95,466 - $142,651	-54,866 Reduced 83.06%	11,188 $23,000

Q2 2021 Aug 12, 2021	BUY	$1.51 - $4.23 $99,741 - $279,408	66,054 New	66,054 $230,000

26.7M

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $140M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.